Nve(NASDAQ) NVEC

NVE makes sensors and couplers that help machines detect movement and send data. Factories use these products to automate tasks and improve safety. Hospitals use NVE’s sensors in medical devices to replace older, mechanical switches.

Gadgets That Sense and Connect: NVE’s Main Offerings

• Product sales: 96.7% of Q2 FY2026 revenue; includes spintronic sensors for position and speed sensing in factory automation and medical devices.
• Custom and medical sensors: Replace mechanical switches in medical equipment; part of the sensor category above.
• Spintronic couplers: Transmit data between machines in industrial Internet of Things (IIoT) systems; included in product sales.
• Contract research and development: Provides custom research services; 3.3% of Q2 FY2026 revenue; supports technology innovation for clients.
• Licensing of MRAM technology: Licenses magnetoresistive random access memory (MRAM) technology to other companies; revenue not separately disclosed.

Growth Moves: NVE’s Expansion Playbook

• Expanded production facilities in 2025 with $1.13 million in new equipment purchases.
• Plans for $1.0–$1.5 million more in production expansion by end of FY2026.
• Shifted resources from research to manufacturing and new product development in 2025.
• Focused on nondefense markets as defense sales became more variable in 2025.

What Makes NVE Stand Out in a Crowd

NVE uses spintronics, a technology that relies on electron spin, not just charge, to sense and transmit data. The company targets niche markets like factory automation and medical devices, where its products replace older, less reliable solutions. NVE’s small team and focus on research allow it to adapt quickly to changing industry needs.

Five Things You Need to Know

• Revenue was $6.35 million in Q2 FY2026, down 6.1% from Q2 FY2025.
• Product sales made up 96.7% of Q2 FY2026 revenue, up 0.6% year-over-year.
• Gross margin fell to 78.3% in Q2 FY2026, from 86.0% in Q2 FY2025.
• Net income was $3.31 million in Q2 FY2026, down 16.3% year-over-year.
• Cash and marketable securities totaled $45.59 million as of September 30, 2025.

Bottom Line

NVE has evolved by focusing on specialized sensors and data couplers for automation and medical markets. The company’s adaptable business model and strong cash position support ongoing innovation and operational flexibility.